Seeger Weiss Reaches $1.1 Billion Personal Injury and Medical Monitoring Settlement in Philips CPAPs, Bi-PAPs, and Ventilators Litigation

Seeger Weiss founder and court-appointed co-lead counsel Chris Seeger secured a nearly $1.1 billion settlement in the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation. The agreement provides $1.075 billion to compensate patients who suffered injuries while using recalled Philips devices and also includes $25 million to cover the cost of medical monitoring […]

May 9, 2024

Seeger Weiss founder and court-appointed co-lead counsel Chris Seeger secured a nearly $1.1 billion settlement in the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation. The agreement provides $1.075 billion to compensate patients who suffered injuries while using recalled Philips devices and also includes $25 million to cover the cost of medical monitoring for potential long-term health risks. Millions of Americans will now receive compensation and justice for the injuries sustained while using defective and recalled Philips respiratory devices containing toxic, sound-reducing foam.

This agreement comes just weeks after the uncapped economic loss settlement, where Philips agreed to a settlement exceeding $500 million for individuals who bought faulty CPAP, Bi-PAP, and ventilator devices. Philips initiated the recall of around 10.8 million devices in the United States on June 21, 2021, citing purported health hazards stemming from toxic sound-dampening foam. The efforts of Seeger Weiss partners David Buchanan, Shauna Itri, and Caleb Seeley, as well as associates Humaira Safdar and Fraz Thomas were instrumental in achieving these settlements.

Plaintiffs’ co-lead counsel (Sandra L. Duggan of Levin Sedran & Berman LLP, Kelly K. Iverson of Lynch Carpenter LLP, Christopher A. Seeger of Seeger Weiss LLP, and Steven A. Schwartz of Chimicles Schwartz Kriner & Donaldson-Smith LLP) said, “We are pleased to have reached a resolution of personal injury and medical monitoring claims for $1.1 billion. The agreements with Philips will provide compensation to those users of the now-recalled CPAP and other respiratory devices who suffer from significant physical injuries and important research for the treatment of those injuries. This is in addition to the uncapped settlement that will provide more than $600 million in economic compensation to affected device owners.”

They added, “Ultimately, these combined agreements accomplish what we sought to achieve when this litigation began — holding Philips accountable by obtaining care for those with physical injuries and compensation for those needing new respiratory devices. We extend our thanks to the court appointed mediator, Judge Diane Welsh, for her invaluable guidance which led to this resolution, and we will provide more information to eligible claimants and their legal counsel once the agreements are finalized and filed.”

One of the nation’s preeminent plaintiffs’ law firms, Seeger Weiss is best known for multidistrict mass torts and class actions in both state and federal court—and especially for taking those cases to trial. With the resources and dedication to take on the world’s largest corporations, the firm has an impressive track record of victories against companies like Merck, Monsanto, and 3M—and a reputation for sticking with a case from beginning to end. From offices in New York, New Jersey, Pennsylvania, and Massachusetts, the firm has represented over 10,000 individuals, companies, and governments across the United States who have been injured or defrauded on a massive scale. Since its founding in 1999, it has led many of the most complex and high-profile cases in the country: the National Prescription Opiate Litigation, which the Washington Post called “the largest federal court case in U.S. history”; the ongoing “Dieselgate” scandal; the sprawling multistate litigation on behalf of survivors of child sexual abuse; and the history-making National Football League Players’ Concussion Injury Litigation.

Compensation is limited to qualified participating claimants. Prior results do not guarantee or predict a similar outcome in any future matter.

Related News

May 13, 2024
Seeger Weiss, Chris Seeger Named Elite Trial Lawyers Plaintiff Firm of the Year and Plaintiff Attorney of the Year Finalists; Parvin Aminolroaya Wins Elite Women of the Plaintiffs Bar Award

Seeger Weiss is pleased to announce that the firm and several of its partners have won or are finalists for multiple 2024 National Law Journal Elite Trial Lawyers Awards. Seeger Weiss was named a finalist for: Plaintiffs Firm of the Year Environmental Protection Practice Group of the Year Government Representation Practice Group of the Year […]

Read More
May 9, 2024
Seeger Weiss Partner Parvin Aminolroaya Appointed Co-lead Counsel In Ozempic Litigation

RIDGEFIELD PARK, NJ — Seeger Weiss is pleased to announce that partner Parvin K. Aminolroaya has been appointed to serve as plaintiffs’ co-lead counsel in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation by the honorable Judge Gene E. K. Pratter. This litigation consolidates dozens of lawsuits against drugmakers Novo Nordisk and Eli […]

Read More
April 26, 2024
Seeger Weiss Secures Final Approval of Philips CPAP Economic Loss Class Action Settlement

On April 25, 2024, Judge Joy Flowers Conti of the Western District of Pennsylvania granted final approval to the economic loss class action settlement negotiated by Seeger Weiss partner Chris Seeger and his fellow co-lead plaintiffs’ counsel in the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation. The uncapped settlement provides more than […]

Read More